Trial Profile
Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide: A Randomized, Double-blind, Placebo-controlled Multicenter Clinical Study
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 10 Nov 2016 New trial record